Table 2.
Median (Me), minimum (min), and maximum (max) serum sHLA-G levels (U/mL) in the women with antiphospholipid syndrome (APS), preeclampsia (PE), intrauterine growth restriction (IUGR), and in the control group (C). Results are from Mann–Whitney U tests.
| Group | n | sHLA-G (U/mL) | ||||
|---|---|---|---|---|---|---|
| Me | Min | Max | Q25 | Q75 | ||
| APS; n = 57 | 57 | 11.90 | 1.00 | 458.00 | 8.00 | 22.20 |
| PE; n = 28 | 28 | 10.10 | 1.70 | 100.20 | 5.25 | 14.55 |
| IUGR; n = 18 | 18 | 14.90 | 2.40 | 160.00 | 4.60 | 37.70 |
| C; n = 72 | 72 | 12.30 | 1.00 | 269.60 | 6.80 | 28.95 |
| Total | 175 | 11.40 | 1.00 | 458.00 | 6.60 | 23.40 |